In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
March 14th, 2009 | 17 | Yes |
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.03 | 8.13 | -6.93 | 1 | 1 | 0 | 20 | 224.303 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 4.29e-03 g/l | DrugBank-experimental |
PUBCHEM_PATENT_ID | US4522907 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
LOX5-1-E | Arachidonate 5-lipoxygenase (cluster #1 Of 6), Eukaryotic | Eukaryotes | 100 | 0.58 | Binding ≤ 10μM |
PGH1-2-E | Cyclooxygenase-1 (cluster #2 Of 6), Eukaryotic | Eukaryotes | 4200 | 0.44 | Binding ≤ 10μM |
PGH2-1-E | Cyclooxygenase-2 (cluster #1 Of 8), Eukaryotic | Eukaryotes | 4200 | 0.44 | Binding ≤ 10μM |
TTHY-1-E | Transthyretin (cluster #1 Of 3), Eukaryotic | Eukaryotes | 3080 | 0.45 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
LOX5_HUMAN | P09917 | Arachidonate 5-lipoxygenase, Human | 100 | 0.58 | Binding ≤ 1μM |
LOX5_HUMAN | P09917 | Arachidonate 5-lipoxygenase, Human | 100 | 0.58 | Binding ≤ 10μM |
PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 4200 | 0.44 | Binding ≤ 10μM |
PGH2_HUMAN | P35354 | Cyclooxygenase-2, Human | 4200 | 0.44 | Binding ≤ 10μM |
TTHY_HUMAN | P02766 | Transthyretin, Human | 3080 | 0.45 | Binding ≤ 10μM |
Description | Species |
---|---|
Amyloids | |
COX reactions | |
Nicotinamide salvaging | |
Non-integrin membrane-ECM interactions | |
Retinoid cycle disease events | |
Retinoid metabolism and transport | |
Synthesis of 15-eicosatetraenoic acid derivatives | |
Synthesis of 5-eicosatetraenoic acids | |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | |
Synthesis of Lipoxins (LX) | |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | |
The canonical retinoid cycle in rods (twilight vision) |